Pulsenmore (TASE: PULS), a provider of home-based ultrasound technology, announced on Wednesday that it has renewed and expanded its partnership with Clalit Health Services, Israel's largest HMO. Over the next five years, Pulsenmore will supply 25,000 advanced home ultrasound devices, enhancing Clalit's commitment to accessible prenatal care.

The Pulsenmore platform allows expectant mothers to conduct ultrasound scans from home, improving access to healthcare. Under the new agreement, devices will enable both asynchronous (App Guided) and synchronous (Clinician Guided) scans through real-time video consultations, empowering women with direct access to quality prenatal care.

Clalit will also explore integrating Pulsenmore's latest home-based Biophysical Profile (BPP) feature, which assists medical teams in assessing fetal well-being and making timely decisions for high-risk pregnancies. The home ultrasound device, connected via smartphone, allows users to perform self-guided scans, with data securely sent to medical professionals for remote evaluation. This intuitive technology captures vital fetal health metrics, including heartbeat, movement, and amniotic fluid levels.

Founded in 2014, Pulsenmore has achieved rapid growth, obtaining regulatory approvals in Israel and Europe, and recently gaining clearance for distribution in Australia and Brazil. The company reported a robust 79% revenue growth in the first half of the year and anticipates committed contractual revenue through 2025, positioning itself as a transformative force in prenatal care.